U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H4ClNOS
Molecular Weight 149.599
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of METHYLCHLOROISOTHIAZOLINONE

SMILES

CN1SC(Cl)=CC1=O

InChI

InChIKey=DHNRXBZYEKSXIM-UHFFFAOYSA-N
InChI=1S/C4H4ClNOS/c1-6-4(7)2-3(5)8-6/h2H,1H3

HIDE SMILES / InChI

Molecular Formula C4H4ClNOS
Molecular Weight 149.599
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: DOI: 10.1007/978-3-642-55706-4_7 http://ec.europa.eu/consumers/sectors/cosmetics/files/pdf/mci_mi/mci_mi_pc_en.pdf Methylisothiazolinone/Methylchloroisothiazolinone (Kathon CG) Allergy: An Updated Review.

Methylchloroisothiazolinone is an active ingredient in many preservatives marketed under various brand names. It is effective against gram-positive and gram-negative bacteria, yeast, and fungi. Pure Methylchloroisothiazolinone is not commercially available. Kathon CG contains a mixture of Methylisothiazolinone (MI) and Methylchloroisothiazolinone (MCI) in ratio 3:1. Kathon was used in various rinse-off and leave-on formulations including hair products, shampoos, skin care products, bath products, eye and facial makeup, wet wipes and suntan products. The Commission envisages amending Annex V of the Cosmetics Regulation (EC) No. 1223/2009 to restrict the use of methylchloroisothiazolinone to rinse-off products, as suggested by the SCCS.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
TRUE Test

Approved Use

5-chloro-2-methyl-4-isothiazolin-3-one (1.05% to 1.25% w/w) and 2-methyl-4-isothiazolin-3-one (0.25% to 0.40% w/w) in a 3:1 ratio at a concentration of 1.5% in aqueous magnesium salts are used to formulate patch #17
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
282 μg/g
2 mg single, oral
dose: 2 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
N-METHYLMALONAMIC ACID urine
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
7.6 h
2 mg single, oral
dose: 2 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
N-METHYLMALONAMIC ACID urine
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
1000 ppm single, topical
Highest studied dose
Dose: 1000 ppm
Route: topical
Route: single
Dose: 1000 ppm
Sources:
healthy, ADULT
Health Status: healthy
Age Group: ADULT
Sex: unknown
Food Status: UNKNOWN
Sources:
Other AEs: Sensitization...
AEs

AEs

AESignificanceDosePopulation
Sensitization 12.5%
1000 ppm single, topical
Highest studied dose
Dose: 1000 ppm
Route: topical
Route: single
Dose: 1000 ppm
Sources:
healthy, ADULT
Health Status: healthy
Age Group: ADULT
Sex: unknown
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
Chemical allergens stimulate human epidermal keratinocytes to produce lymphangiogenic vascular endothelial growth factor.
2015-03-01
B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry.
2012-03-25
The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study in five laboratories.
2011-04
Analysis of isothiazolinone biocides in paper for food packaging by ultra-high-performance liquid chromatography-tandem mass spectrometry.
2010-12
Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes.
2010-11-10
Prevalence and cause of methylisothiazolinone contact allergy.
2010-09
A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells.
2010-09
Methylchloroisothiazolinone / methylisothiazolinone and moist wipe dermatitis.
2010-05-15
Consumer exposure to biocides--identification of relevant sources and evaluation of possible health effects.
2010-02-03
Concomitant contact allergy to methylchloroisothiazolinone/methylisothiazolinone and formaldehyde-releasing preservatives.
2010-01
Mechanistic assessment of peptide reactivity assay to predict skin allergens with Kathon CG isothiazolinones.
2009-04
Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals.
2009-04
Role of intracellular calcium and S-glutathionylation in cell death induced by a mixture of isothiazolinones in HL60 cells.
2009-03
Methyl gallate.
2009-01-14
Alkalization of wall paint prevents airborne contact dermatitis in patients with sensitization to isothiazolinones.
2008-08
Suitability of macrophage inflammatory protein-1beta production by THP-1 cells in differentiating skin sensitizers from irritant chemicals.
2008-04
Airborne allergic contact dermatitis to methylchloroisothiazolinone/methylisothiazolinone in ironing water.
2008-03
Different regulation of T helper 1- and T helper 2-promoting cytokine signalling factors in human dendritic cells after exposure to protein versus contact allergens.
2008-01
Quantitative relationships between patch test reactivity and use test reactivity: an overview.
2008
Analysis of isothiazolinones in environmental waters by gas chromatography-mass spectrometry.
2007-09-14
Iron dependent degradation of an isothiazolone biocide (5-chloro-2-methyl-4-isothiazolin-3-one).
2007
Preservatives sensitivity in Israel: a 10-year overview (1995-2004).
2006-10
GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells.
2006-02
Patch testing with patients' own cosmetics and toiletries--results of the IVDK*, 1998-2002.
2005-10
Oxidative stress in mouse skin following application of contact allergenic 5-chloro-2-methyl-4-isothiazolin-3-one and oxazolone.
2005-03
From experiment to theory: molecular orbital parameters to interpret the skin sensitization potential of 5-chloro-2-methylisothiazol-3-one and 2-methylisothiazol-3-one.
2005-02
Effect of glutathione on the covalent binding of the 13C-labeled skin sensitizer 5-chloro-2-methylisothiazol-3-one to human serum albumin: identification of adducts by nuclear magnetic resonance, matrix-assisted laser desorption/ionization mass spectrometry, and nanoelectrospray tandem mass spectrometry.
2004-09
Covalent binding of the 13C-labeled skin sensitizers 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI) to a model peptide and glutathione.
2004-01-19
Contact sensitization to 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one in children.
2003-10
Co-existing sensitivity to metronidazole and isothiazolinone.
2003-09
Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal human keratinocytes.
2003-08
Studies of chemical selectivity of hapten, reactivity, and skin sensitization potency. 3. Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI).
2003-05
Coupling of contact sensitizers to thiol groups is a key event for the activation of monocytes and monocyte-derived dendritic cells.
2003-02
Audit of Finn Chamber patch test preparation.
2002-12
Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment.
2002-08-01
Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000).
2002-04
In vitro induction of apoptosis vs. necrosis by widely used preservatives: 2-phenoxyethanol, a mixture of isothiazolinones, imidazolidinyl urea and 1,2-pentanediol.
2002-02-01
Patents

Patents

Sample Use Guides

3 mcg of 5-chloro-2-methyl-4-isothiazolin-3-one (1.05% to 1.25% w/w) and 2-methyl-4-isothiazolin-3-one (0.25% to 0.40%w/w) in a 3:1 ratio per patch. Schedule patients to return approximately 48 hours after patch test application to have the panels removed.
Route of Administration: Topical
In Vitro Use Guide
Curator's Comment: Kathon is active at concentrations of 2.25–9 mg/mL active ingredients against a wide range of bacteria and fungi. https://www.google.ru/url?sa=t&rct=j&q=&esrc=s&source=web&cd=6&ved=0ahUKEwinisCBq8bPAhXI8ywKHWDrAJ8QFghGMAU&url=https%3A%2F%2Ffaculty.psau.edu.sa%2Ffiledownload%2Fdoc-7-pdf-61f3024ed641390e498517b310f7a378-original.pdf&usg=AFQjCNETPmioZMn6G6wNkDUJ6dSIgh59tA&sig2=uKNYTfPwwpRk83zu8Y96zA&bvm=bv.134495766,d.bGg
5-Chloro-2-methyl-4-isothiazolin-3-one inhibited growth in all test strains of Salmonella typhimurium without activation. A statistically significant increase in the number of revertants in strain TA100 was observed without activation at concentrations of 0.20, 0.25 and 0.30 ug/plate and in 2 of the 3 trials at 0.10 ug/plate.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:10:28 GMT 2025
Edited
by admin
on Mon Mar 31 18:10:28 GMT 2025
Record UNII
DEL7T5QRPN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
METHYLCHLOROISOTHIAZOLINONE
II   INCI   MART.   VANDF  
INCI  
Official Name English
A 33
Preferred Name English
5-CHLORO-2-METHYL-3-ISOTHIAZOLONE
Systematic Name English
METHYLCHLOROISOTHIAZOLINONE [II]
Common Name English
METHYLCHLOROISOTHIAZOLINONE [MART.]
Common Name English
5-CHLOR-2-METHYL-4-ISOTHIAZOLIN-3-ONE
Common Name English
A-33
Code English
METHYLCHLOROISOTHIAZOLINONE [MI]
Common Name English
3(2H)-ISOTHIAZOLONE, 5-CHLORO-2-METHYL-
Systematic Name English
5-CHLORO-N-METHYLISOTHIAZOLONE
Systematic Name English
Methylchloroisothiazolinone [WHO-DD]
Common Name English
5-CHLORO-2-METHYL-2H-ISOTHIAZOL-3-ONE
Systematic Name English
5-CHLORO-2-METHYL-ISOTHIAZOL-3-ONE
Systematic Name English
5-CHLORO-2-METHYL-3(2H)-ISOTHIAZOLONE
Systematic Name English
N-METHYL-5-CHLOROISOTHIAZOLONE
Systematic Name English
N-METHYL-5-CHLOROISOTHIAZOLIN-3-ONE
Systematic Name English
METHYLCHLOROISOTHIAZOLINONE [VANDF]
Common Name English
HS 818
Code English
NEOLONE 950
Brand Name English
5-CHLORO-2-METHYLISOTHIAZOLIN-3-ONE
Systematic Name English
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
Systematic Name English
4-ISOTHIAZOLIN-3-ONE, 5-CHLORO-2-METHYL-
Systematic Name English
5-CHLORO-N-METHYLISOTHIAZOLIN-3-ONE
Systematic Name English
HS-818
Code English
2-METHYL-5-CHLOROISOTHIAZOLIN-3-ONE
Systematic Name English
2-METHYL-5-CHLORO-3-ISOTHIAZOLONE
Systematic Name English
5-CHLORO-2-METHYL-3(2H)-ISOTHIAZOLINONE
Systematic Name English
Classification Tree Code System Code
Food Contact Sustance Notif, (FCN No.) FCN NO. 704
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 999
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 569
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
EPA PESTICIDE CODE 107103
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
Food Contact Sustance Notif, (FCN No.) FCN NO. 675
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
NDF-RT N0000185508
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
CFR 21 CFR 176.170
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
CFR 21 CFR 175.320
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
Code System Code Type Description
MESH
C011421
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
EVMPD
SUB23424
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
DRUG BANK
DB14197
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
FDA UNII
DEL7T5QRPN
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
RXCUI
1367119
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY RxNorm
NDF-RT
N0000175629
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY Increased Histamine Release [PE]
MERCK INDEX
m7433
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
SMS_ID
100000088728
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
CHEBI
53621
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
PUBCHEM
33344
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
WIKIPEDIA
METHYLCHLOROISOTHIAZOLINONE
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
ECHA (EC/EINECS)
247-500-7
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
NDF-RT
N0000171131
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY Allergens [Chemical/Ingredient]
CFR
21 CFR 176.300
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
CAS
26172-55-4
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
NDF-RT
N0000184306
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY Cell-mediated Immunity [PE]
HSDB
8270
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
EPA CompTox
DTXSID9034286
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
DAILYMED
DEL7T5QRPN
Created by admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY